TCT-455 Clinical Outcomes in the Percutaneous Coronary Intervention of In-Stent Restenosis with the XIENCE V Everolimus-Eluting Stent

Though percutaneous coronary intervention with the XIENCE V(r) everolimus-eluting stent (EES, Abbott Vascular, Santa Clara, CA) for native coronary artery disease has favorable results compared to first generation drug-eluting stents, outcomes with EES for the treatment of in-stent restenosis (ISR)